Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 346

1.

The impact of CPJ on practice: An update.

Kung JY, Lipowski J, Tsuyuki RT.

Can Pharm J (Ott). 2019 Oct 14;152(6):357-361. doi: 10.1177/1715163519878659. eCollection 2019 Nov-Dec. No abstract available.

2.

Economic Evaluation of Pharmacists Tackling the Burden of Hypertension in Japan.

Okada H, Johnston K, Nakayama T, Marra C, Tsuyuki RT.

Hypertension. 2019 Dec;74(6):e54-e55. doi: 10.1161/HYPERTENSIONAHA.119.13527. Epub 2019 Oct 14. No abstract available.

PMID:
31607176
3.

Cost analysis and efficacy of recruitment strategies used in a large pragmatic community-based clinical trial targeting low-income seniors: a comparative descriptive analysis.

Kakumanu S, Manns BJ, Tran S, Saunders-Smith T, Hemmelgarn BR, Tonelli M, Tsuyuki R, Ivers N, Southern D, Bakal J, Campbell DJT.

Trials. 2019 Oct 7;20(1):577. doi: 10.1186/s13063-019-3652-5.

4.

Outcomes of nurse practitioner-led care in patients with cardiovascular disease: A systematic review and meta-analysis.

Smigorowsky MJ, Sebastianski M, Sean McMurtry M, Tsuyuki RT, Norris CM.

J Adv Nurs. 2019 Oct 7. doi: 10.1111/jan.14229. [Epub ahead of print] Review.

PMID:
31588598
5.

A Cost Analysis and Cost-Utility Analysis of a Community Pharmacist-Led Intervention on Reducing Cardiovascular Risk: The Alberta Vascular Risk Reduction Community Pharmacy Project (RxEACH).

Tam-Tham H, Clement F, Hemmelgarn BR, Manns BJ, Klarenbach SW, Tonelli M, Tsuyuki RT, Al Hamarneh YN, Penko J, Weaver CGW, Au F, Weaver RG, Jones CA, McBrien KA.

Value Health. 2019 Oct;22(10):1128-1136. doi: 10.1016/j.jval.2019.05.012. Epub 2019 Aug 17.

PMID:
31563255
6.

Barriers to a full scope of pharmacy practice in primary care: A systematic review of pharmacists' access to laboratory testing.

Donovan J, Tsuyuki RT, Al Hamarneh YN, Bajorek B.

Can Pharm J (Ott). 2019 Aug 6;152(5):317-333. doi: 10.1177/1715163519865759. eCollection 2019 Sep-Oct. Review.

7.

A call to action to implement prescribing authority to pharmacists for hypertension management.

Khan N, Bell A, Berg A, Campbell N, Kaczorowski J, Rabi D, Schiffrin EL, Tsuyuki RT.

Can Pharm J (Ott). 2019 Jul 22;152(5):285-287. doi: 10.1177/1715163519866144. eCollection 2019 Sep-Oct. No abstract available.

8.

Reply.

Beahm NP, Smyth DJ, Tsuyuki RT.

Can Pharm J (Ott). 2019 Aug 8;152(5):283. doi: 10.1177/1715163519867257. eCollection 2019 Sep-Oct. No abstract available.

9.

Pharmacists' professional identity: A foundational problem (and solution) for our profession.

Tsuyuki RT.

Can Pharm J (Ott). 2019 Aug 8;152(5):277-280. doi: 10.1177/1715163519866395. eCollection 2019 Sep-Oct. No abstract available.

10.

Community pharmacist counseling in early pregnancy-Results from the SafeStart feasibility study.

Truong MB, Ngo E, Ariansen H, Tsuyuki RT, Nordeng H.

PLoS One. 2019 Jul 19;14(7):e0219424. doi: 10.1371/journal.pone.0219424. eCollection 2019.

11.

Pharmacist prescribing and care improves cardiovascular risk, but is it cost-effective? A cost-effectiveness analysis of the RxEACH study.

Al Hamarneh YN, Johnston K, Marra CA, Tsuyuki RT.

Can Pharm J (Ott). 2019 Jun 10;152(4):257-266. doi: 10.1177/1715163519851822. eCollection 2019 Jul-Aug.

12.

Case finding for urinary incontinence and falls in older adults at community pharmacies.

Duong E, Al Hamarneh YN, Tsuyuki RT, Wagg A, Hunter KF, Schulz J, Spencer M, Sadowski CA.

Can Pharm J (Ott). 2019 Jun 12;152(4):228-233. doi: 10.1177/1715163519852378. eCollection 2019 Jul-Aug. No abstract available.

13.

The evolution of pharmacy practice research-Part II: Time to join the rest of the world.

Bond C, Tsuyuki RT.

Can Pharm J (Ott). 2019 Jun 12;152(4):219-220. doi: 10.1177/1715163519852914. eCollection 2019 Jul-Aug. No abstract available.

14.

Cost-effectiveness and budget impact of the management of uncomplicated urinary tract infection by community pharmacists.

Sanyal C, Husereau DR, Beahm NP, Smyth D, Tsuyuki RT.

BMC Health Serv Res. 2019 Jul 18;19(1):499. doi: 10.1186/s12913-019-4303-y.

15.

Are Preeclampsia and Adverse Obstetrical Outcomes Predictors of Cardiovascular Disease? A Case-Control Study of Women With Heart Disease.

Sia WW, Pertman SM, Yan RM, Tsuyuki RT.

J Obstet Gynaecol Can. 2019 Dec;41(12):1760-1767. doi: 10.1016/j.jogc.2019.03.023. Epub 2019 Jul 3.

PMID:
31279766
16.

Nouvelle stratégie du Canada en matière de saine alimentation: Implications pour les professionnels de la santé et appel à l’action.

Bacon SL, Campbell NRC, Raine KD, Tsuyuki RT, Khan NA, Arango M, Kaczorowski J.

Can Fam Physician. 2019 Jun;65(6):e244-e250. French. No abstract available.

PMID:
31189637
Free PMC Article
17.

Canada's new Healthy Eating Strategy: Implications for health care professionals and a call to action.

Bacon SL, Campbell NRC, Raine KD, Tsuyuki RT, Khan NA, Arango M, Kaczorowski J.

Can Fam Physician. 2019 Jun;65(6):393-398. No abstract available.

18.

Pharmacists to improve hypertension management: Guideline concordance from North America to Europe.

Anker D, Tsuyuki RT, Paradis G, Chiolero A, Santschi V.

Can Pharm J (Ott). 2019 Apr 16;152(3):180-185. doi: 10.1177/1715163519839675. eCollection 2019 May-Jun. Review. No abstract available.

19.

Canada's new Healthy Eating Strategy: Implications for health care professionals and a call to action.

Bacon SL, Campbell NRC, Raine KD, Tsuyuki RT, Khan NA, Arango M, Kaczorowski J.

Can Pharm J (Ott). 2019 Mar 10;152(3):151-157. doi: 10.1177/1715163519834891. eCollection 2019 May-Jun. No abstract available.

20.

Dietary sodium and the health of Canadians.

Campbell N, Bacon S, Tsuyuki R, Arango M, Raine K, Kaczorowski J.

Can Pharm J (Ott). 2019 Apr 16;152(3):147. doi: 10.1177/1715163519840376. eCollection 2019 May-Jun. No abstract available.

21.

Regulation and innovation in practice - Not a "drug interaction"?

Tsuyuki RT, Nakagawa RS.

Can Pharm J (Ott). 2019 Apr 2;152(3):143-144. doi: 10.1177/1715163519839040. eCollection 2019 May-Jun. No abstract available.

22.

The evolution of pharmacy practice research - Part II: Time to join the rest of the world.

Bond C, Tsuyuki R.

Int J Pharm Pract. 2019 Jun;27(3):219-220. doi: 10.1111/ijpp.12545. No abstract available.

PMID:
31111987
23.

Outcomes of Urinary Tract Infection Management by Pharmacists (RxOUTMAP): A study of pharmacist prescribing and care in patients with uncomplicated urinary tract infections in the community.

Beahm NP, Smyth DJ, Tsuyuki RT.

Can Pharm J (Ott). 2018 Jun 3;151(5):305-314. doi: 10.1177/1715163518781175. eCollection 2018 Sep-Oct.

24.

Time to give up on expanded scope of practice.

Tsuyuki RT, Houle SKD, Okada H.

Can Pharm J (Ott). 2018 Aug 17;151(5):286. doi: 10.1177/1715163518793844. eCollection 2018 Sep-Oct. No abstract available.

25.

Statin use and the risk of acute kidney injury in older adults.

Tonelli M, Lloyd AM, Bello AK, James MT, Klarenbach SW, McAlister FA, Manns BJ, Tsuyuki RT, Hemmelgarn BR; Alberta Kidney Disease Network.

BMC Nephrol. 2019 Mar 25;20(1):103. doi: 10.1186/s12882-019-1280-7.

26.

Remunerated patient care services and injections by pharmacists: An international update.

Houle SKD, Carter CA, Tsuyuki RT, Grindrod KA.

Can Pharm J (Ott). 2019 Jan 24;152(2):92-108. doi: 10.1177/1715163518811065. eCollection 2019 Mar-Apr. Review.

27.

The evolution of pharmacy practice research-Part I: Time to implement the evidence.

Tsuyuki RT, Bond C.

Can Pharm J (Ott). 2019 Feb 17;152(2):71-72. doi: 10.1177/1715163519828318. eCollection 2019 Mar-Apr. No abstract available.

28.

Canada's New Healthy Eating Strategy: Implications for Healthcare Professionals and a Call to Action.

Bacon SL, Campbell NRC, Raine KD, Tsuyuki R, Khan NA, Arango M, Kaczorowski J.

Can J Diabetes. 2019 Apr;43(3):155-160. doi: 10.1016/j.jcjd.2019.02.001. Epub 2019 Mar 15. No abstract available.

PMID:
30885575
29.

Acute coronary syndromes presentations and care outcomes in white, South Asian and Chinese patients: a cohort study.

King-Shier K, Quan H, Kapral MK, Tsuyuki R, An L, Banerjee S, Southern DA, Khan N.

BMJ Open. 2019 Mar 13;9(3):e022479. doi: 10.1136/bmjopen-2018-022479.

30.

The evolution of pharmacy practice research-Part I: Time to implement the evidence.

Tsuyuki R, Bond C.

Int J Pharm Pract. 2019 Apr;27(2):109-111. doi: 10.1111/ijpp.12527. No abstract available.

PMID:
30860315
31.

Reply from the authors.

Tsuyuki RT, Okada H, Houle SKD.

Can Pharm J (Ott). 2018 Dec 17;152(1):9. doi: 10.1177/1715163518816044. eCollection 2019 Jan-Feb. No abstract available.

32.

A leadership crisis in pharmacy.

Tsuyuki RT.

Can Pharm J (Ott). 2018 Dec 12;152(1):6-7. doi: 10.1177/1715163518816963. eCollection 2019 Jan-Feb. No abstract available.

33.

Evidence and its impact on pharmacy practice: Don't be "evidence-illiterate".

Sanyal C, Husereau D, Tsuyuki RT.

Can Pharm J (Ott). 2018 Oct 11;151(6):357-358. doi: 10.1177/1715163518805404. eCollection 2018 Nov-Dec. No abstract available.

34.

Cardiovascular Efficacy and Safety of PCSK9 Inhibitors: Systematic Review and Meta-analysis Including the ODYSSEY OUTCOMES Trial.

Turgeon RD, Tsuyuki RT, Gyenes GT, Pearson GJ.

Can J Cardiol. 2018 Dec;34(12):1600-1605. doi: 10.1016/j.cjca.2018.04.002.

PMID:
30527147
35.

Pharmacist prescribing and care improves cardiovascular risk, but what do patients think? A substudy of the RxEACH study.

Al Harmarneh YN, Lamb S, Donald M, Hemmelgarn B, King Shier K, Jones CA, Mitchell C, Tsuyuki RT.

Can Pharm J (Ott). 2018 May 30;151(4):223-227. doi: 10.1177/1715163518779092. eCollection 2018 Jul-Aug. No abstract available.

36.

FAQs (frequent asinine questions) on pharmacists' scope of practice.

Tsuyuki RT.

Can Pharm J (Ott). 2018 Jun 4;151(4):212-213. doi: 10.1177/1715163518779790. eCollection 2018 Jul-Aug. No abstract available.

37.

Remunerated patient care services and injections by pharmacists: An international update.

Houle SKD, Carter CA, Tsuyuki RT, Grindrod KA.

J Am Pharm Assoc (2003). 2019 Jan - Feb;59(1):89-107. doi: 10.1016/j.japh.2018.07.002. Epub 2018 Sep 6.

PMID:
30195440
38.

Development of clinical pharmacy services in Australia, Austria, Belgium, Bosnia-Herzegovina, Canada, Germany, Japan, Kosovo, Switzerland, the Netherlands, Thailand, USA and correlation with educational standards, level of research, and implemen.

Rose O, Derendorf H, Erzkamp S, Fujita K, Hartl A, Hoti K, Krass I, Obarcanin E, Saevels J, Srimongkon P, Teichert M, Tsuyuki RT.

Int J Clin Pharmacol Ther. 2018 Nov;56(11):518-530. doi: 10.5414/CP203264.

PMID:
30106363
39.

Reply from authors.

Lamb SA, Al Hamarneh YN, Houle SKD, Leung AA, Tsuyuki RT.

Can Pharm J (Ott). 2018 May 4;151(3):158. doi: 10.1177/1715163518767828. eCollection 2018 May-Jun. No abstract available.

40.

Pharmacists as cognitive authorities: Why this is important in advancing patient care and our profession.

Tsuyuki RT, Hirsh J.

Can Pharm J (Ott). 2018 May 4;151(3):155-156. doi: 10.1177/1715163518767827. eCollection 2018 May-Jun. No abstract available.

41.

Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children.

Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Padwal RS, Tran KC, Grover S, Rabkin SW, Moe GW, Howlett JG, Lindsay P, Hill MD, Sharma M, Field T, Wein TH, Shoamanesh A, Dresser GK, Hamet P, Herman RJ, Burgess E, Gryn SE, Grégoire JC, Lewanczuk R, Poirier L, Campbell TS, Feldman RD, Lavoie KL, Tsuyuki RT, Honos G, Prebtani APH, Kline G, Schiffrin EL, Don-Wauchope A, Tobe SW, Gilbert RE, Leiter LA, Jones C, Woo V, Hegele RA, Selby P, Pipe A, McFarlane PA, Oh P, Gupta M, Bacon SL, Kaczorowski J, Trudeau L, Campbell NRC, Hiremath S, Roerecke M, Arcand J, Ruzicka M, Prasad GVR, Vallée M, Edwards C, Sivapalan P, Penner SB, Fournier A, Benoit G, Feber J, Dionne J, Magee LA, Logan AG, Côté AM, Rey E, Firoz T, Kuyper LM, Gabor JY, Townsend RR, Rabi DM, Daskalopoulou SS; Hypertension Canada.

Can J Cardiol. 2018 May;34(5):506-525. doi: 10.1016/j.cjca.2018.02.022. Epub 2018 Mar 1.

PMID:
29731013
42.

Hot joints: myth or reality? A thermographic joint assessment of inflammatory arthritis patients.

Jones B, Hassan I, Tsuyuki RT, Dos Santos MF, Russell AS, Yacyshyn E.

Clin Rheumatol. 2018 Sep;37(9):2567-2571. doi: 10.1007/s10067-018-4108-0. Epub 2018 Apr 20.

PMID:
29679167
43.

Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention and treatment of hypertension in adults for pharmacists: An update.

Lamb SA, Al Hamarneh YN, Houle SKD, Leung AA, Tsuyuki RT.

Can Pharm J (Ott). 2017 Nov 29;151(1):33-42. doi: 10.1177/1715163517743525. eCollection 2018 Jan-Feb. No abstract available.

44.

Pharmacists as accessible primary health care providers: Review of the evidence.

Tsuyuki RT, Beahm NP, Okada H, Al Hamarneh YN.

Can Pharm J (Ott). 2018 Jan 2;151(1):4-5. doi: 10.1177/1715163517745517. eCollection 2018 Jan-Feb. No abstract available.

45.

Effects of lifestyle advice provided by pharmacists on blood pressure: The COMmunity Pharmacists ASSist for Blood Pressure (COMPASS-BP) randomized trial.

Okada H, Onda M, Shoji M, Sakane N, Nakagawa Y, Sozu T, Kitajima Y, Tsuyuki RT, Nakayama T.

Biosci Trends. 2018 Jan 9;11(6):632-639. doi: 10.5582/bst.2017.01256. Epub 2017 Dec 18.

46.

Active versus passive adverse event reporting after pediatric chiropractic manual therapy: study protocol for a cluster randomized controlled trial.

Pohlman KA, Carroll L, Tsuyuki RT, Hartling L, Vohra S.

Trials. 2017 Dec 1;18(1):575. doi: 10.1186/s13063-017-2301-0.

47.

Innovative pharmacy practice: Lonni Johnson.

Beahm NP, Tsuyuki RT.

Can Pharm J (Ott). 2017 Jul 7;150(4):233-235. doi: 10.1177/1715163517713486. eCollection 2017 Jul-Aug. No abstract available.

48.

Authors' response.

Bachynsky JA, Tsuyuki RT.

Can Pharm J (Ott). 2017 Jul 7;150(4):228. doi: 10.1177/1715163517715013. eCollection 2017 Jul-Aug. No abstract available.

49.

The ultimate opportunity for advancing pharmacy practice.

Tsuyuki RT, Berg A, Khan NA.

Can Pharm J (Ott). 2017 Jun 1;150(4):225-226. doi: 10.1177/1715163517712938. eCollection 2017 Jul-Aug. No abstract available.

50.

Innovative pharmacy practice: Cathy Biggs.

Beahm NP, Tsuyuki RT.

Can Pharm J (Ott). 2017 Oct 5;150(6):359-361. doi: 10.1177/1715163517735310. eCollection 2017 Nov-Dec. No abstract available.

Supplemental Content

Loading ...
Support Center